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INTRODUCTION 
The word Arshas is self-explainatory by itself 
indicating that the disease haunts a person like an 
enemy.
[1]
 
Arshas is the commonest condition among the 
anorectal diseases in our day-to-day practice in terms 
of incidence. It is a very disagreeable condition for the 
patient and often creates restlessness.  
Arshas – one among the Mahagadas mentioned by 
Susruta,
[2]
 the father of Ancient Indian Surgery, which 
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is not amenable for treatment.
[3]
 All the Brihatrayi and 
Laghutrayi have given the detailed description 
regarding the disease Arshas. 
Modern Science has very little to offer in terms of 
medicinal treatments of haemorrhoids. Surgical 
techniques of performing haemorrhoidectomy are 
many and their complications such as pain, anal 
incontinence, stricture etc. are well known. The major 
drawbacks of modern management are lack of clear 
and unanimous indications of therapy and its 
limitations. They are adoptable mostly in fully 
equipped big hospitals. Rubber band ligation and 
injection therapy are the only procedures that can be 
adopted in comparatively smaller clinics but their use 
in the management is limited as it needs special 
training and skill, the results are not very satisfactory 
and complications are many. 
The therapeutic measures should be such which have 
clear indications of their applicability and limitations, 
could be arranged indigenously from local resources, 
the technique should be simple, the complications 
must be minimum and easily manageable, it should be 
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acceptable to the patient and convenient for the 
surgeon, could be introduced in a small clinic and also 
with minimum interference in patients day to day 
activity.  
Management of Arshas only on Ayurvedic lines seems 
to satisfy these criteria. Sushruta, basically a surgeon 
described four principal therapeutic measures in the 
management of Arshas, viz. medicinal, chemical 
cauterization, thermal cauterization and surgical 
excision.
[4]
 It may be pointed out here that 
enumeration of these measures in a definite order is 
suggestive of similar methods to be preferred first.  
By keeping all these principles in mind a herbal 
formulation by name Surana Modaka is prepared to 
see its efficacy in Arshas. 
Therapeutic action of Surana Modaka 
Charaka has described the general properties of the 
medicines indicated for internal administration in the 
condition of Arshas, which are as follows; 
1. Dipana 
2. Pachana 
3. Anulomana 
4. Samshamana 
5. Rakta Sangrahi 
To check out the above properties an attempt is made 
to list the actions of ingredients of Surana Modaka 
which are as follows; 
SN Drug Properties 
1. Chitaraka
[5] 
Deepana, Truptigna, Shoola 
Prashamana, Bhedana, 
Arshoghna, Lekhana, 
Vatakapha Shamaka, Pitta 
Vardhaka. 
2. Ardraka
[6] 
Truptighna, Arshoghna, 
Deepana, Shoolaprashamana, 
Trushnanigrahana, 
Kaphavataghna. 
3. Maricha
[7] 
Deepana, Krumighna, 
Shoolaprashamana, 
Vatakapha Shamaka, Pitta 
Vardhaka. 
4. Haritaki
[8] 
Prajastapana, Jwaraghna, 
Kustaghna, Kasaghna, 
Arshooghna, Vatapitta and 
Kaphaghna. 
5. Bibhitaki
[9] Jwaraghna, Virechanopaga, 
Tridoshanashaka. 
6. Amalaki
[10] Vayasthapana, 
Virechanopaga, Tridoshahara. 
7. 
Pippali
[11]
 and 
Pippali Moola 
Deepana, Shoolaprashamana, 
Tridoshahara. 
8. Talisa patra
[12] Shirovirechana, Kaphavata 
Shamaka. 
9. Talamooli
[13] Vrushya, Rasayana, 
Tridoshahara. 
10. Bhallataka
[14] 
Deepana, Kushtaghna, 
Kaphavata Shamaka, Pitta 
Samshodhaka. 
11. Vidanga
[15] 
Vata Kapha Nashaka, 
Krumighna, Truptighna, 
Shirovirechana. 
12. Vruddhadaru
[16] Adhobhagahara, Deepaka and 
Kaphavata Shamaka 
13. Twak
[17] 
Deepaka, Pachaka, 
Vatakaphanashaka and 
Pittavardhaka. 
14. Ela
[18] Swasahara, Shirovirechana, 
Tridoshahara. 
15. Surana
[19] Ruchya, Deepaka, Pachaka, 
Arshoghna, Vatakapha 
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Shamaka. 
16. Guda
[20] 
Laghu, Patya, Anabhishyandi, 
Agnivruddhikara, Pittahara, 
Madhura, Vrushya, Vatahara, 
Raktadhoshahara. 
The ingredients are arranged so scientifically that 
definitely they help in breaking the Samprapti of 
Arshas. The drugs included in the Yoga are either 
Vatakapha Shamaka or Tridosha Shamaka in nature. 
Arsha which is of Tridoshaja in nature may be better 
benefited by using this Yoga. Some of the ingredients 
are having Vrushya or Rasayana properties. Rasayana 
drugs helps to avoid the recurrence of any disease. So 
after analyzing the ingredients we can say Surana 
Modaka is a better Bheshaja group of medicine 
explained by Cakradatta.
[21] 
MATERIALS AND METHODS  
In this clinical study 10 patients suffering from Arshas 
were selected at random. A detailed history was 
obtained and recorded in a proforma designed 
specifically for this study. The selected 10 patients 
were accessed as per the criteria listed in the specific 
proforma and all findings were recorded. After 30 
days of medication they were examined for findings 
and accessed according to the assessment criteria 
mentioned in the proforma. Incidence observations 
were made and the before treatment and after 
treatment assessment criteria were recorded and 
analysed for statistical significance. Follow up was 
done fortnightly for 3 months. During which all 
assessment criteria were recorded.  
Source of data 
Patients diagnosed as Arshas were taken for the study 
from O.P.D section of S.D.M Ayurveda Hospital, 
Udupi.  
Method of collection of data 
Study design 
Single blind within group comparative study with pre-
test and post-test design. Ten patients with 
complaints of Arsha attending the O.P.D. of S.D.M. 
Ayurveda Hospital, Udupi were randomly selected as 
a single group. Data regarding history, duration of 
illness, findings on clinical examinations and other 
relevant information were recorded in a BT/AT 
proforma, designed specifically for this study. The 
proforma was designed based on clinical features of 
the condition, Arshas vis a vis Haemorrhoids. 
Inclusion criteria 
 Patients between the age group of 20-45 years  
 1
st
 and 2
nd
 degree internal Haemorrhoids. 
Exclusion criteria 
 Pregnancy  
 Age group below 20 years and above 45 years. 
 3
rd
 degree haemorrhoids. 
 Thrombosed haemorrhoids. 
 Patients with systemic illness. 
Intervention 
The patients were advised to take Surana Modaka 12g 
1 teaspoon with warm water half an hour before food 
twice daily i.e. in the morning and evening for 30 
days. After which the patients were examined for 
findings. Subsequent follow up was done fortnightly 
for 3 months. 
Parameters of assesement 
The assesement criteria were listed according to the 
details of clinical features found in Ayurvedic texts 
and contemporary medical books. The criteria were 
grouped as subjective. All the features were recorded 
before treatment and after treatment in the 
proforma.  
Subjective features 
Vibhanda: This feature was graded based on how 
often the patient passed motions. The grading was as 
follows. 
Symptom  Grading 
Every day 0 
3
rd
 day 1 
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4
th
 day 2 
5
th
 day or more 3 
Kandu: The grading was done according to the 
description given by the patient. 
Symptom Grading Features  
Absent 0 No itching 
Mild 1 
Occassional itching sensation 
before and after the 
defecation. 
Moderate 2 
Frequent itching sensation 
with the gap of half to one 
hour. 
Severe 3 
Continous itching sensation 
all through the day in the 
complete peri anal region. 
Raktasrava: Bleeding was seen in some cases. 
Attempts were also made to have a gross quantitative 
analysis of bleeding in terms of profuse, moderate or 
mild.  
Symptom Grading Features 
Absent 0 No bleeding 
Mild 1 
Bleeding  in drops occurring 
once or twice a week 
Moderate 2 
Bleeding in drops continuous 
for 7 to 10 days 
Profuse 3 
Bleeding in streams or drops 
and continuous for more than 
10 days 
OBSERVATIONS 
All the subjective criteria were observed before 
treatment (BT) and after treatment (AT). They were 
tabulated and analysed for statistical significance as 
follows; 
Vibhanda: The severity of constipation was tabulated 
before and after treatment. Among the 10 patients of 
the study 1 patient (10%) has severe constipation 
(grading 3) BT. Among these all the patients who had 
the symptoms BT except one, became symptom free 
AT. In 1 patient in whom the symptom was severe 
(Grading 3) BT, it reduced to mild (Grading 1) AT.  
Group Mean 
Standard 
deviation 
Standard 
Error mean 
Constipation 
BT 
1.900 0.568 0.180 
Constipation 
AT 
0.100 0.316 0.100 
Difference 1.800 0.422 0.133 
t = 13.500 with 9 degree of freedom (p=<0.001) 
The change that occurred with the treatment is 
greater than would be expected by chance. There is 
statistically significant change (p=<0.001).  
Kandu: As per the grading in the proforma the BT and 
AT values of the symptom of Kandu (Pruritus) were 
recorded. Among the 10 patients of the study 6 
patients (60%) had moderate pruritus (Grading 2) and 
4 patients (40%) had mild pruritus (grading 1) BT. 
Among these all the patients who had the symptom 
BT, except 2 became symptom free AT. In the 2 
patients in those the symptom were moderate 
(Grading 2) BT it reduced to mild (Grading 1) AT.  
Group Mean 
Standard 
deviation 
Standard 
Error mean 
Pruritus BT 1.600 0.516 0.163 
Pruritus AT 0.200 0.422 0.133 
Difference 1.400 0.516 0.163 
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t = 8.573 with 9 degree of freedom (p=<0.001). 
The change that occurred with the treatment is 
greater than would be expected by chance. There is 
statistically significant change (p=<0.001). 
Raktasrava: The BT and AT values of bleeding were 
recorded. Among the 10 patients of Arshas, 6 patients 
were having moderate bleeding (Grading 2) BT. This 
moderate bleeding was reduced to mild bleeding 
(Grading 1) AT. Among the 10 patients 4 patients 
(40%) had mild bleeding (Grading 1) BT. After 
treatment there was no bleeding (Grading 0) in these 
4 patients. 
Group Mean 
Standard 
deviation 
Standard 
Error mean 
Bleeding 
BT 
1.600 0.516 0.163 
Bleeding 
AT 
0.600 0.516 0.163 
Difference 1.000 0.000 0.000 
t =< 1.20 with 9 degree of freedom (p=<0.001). 
The change that occurred with the treatment is 
greater than would be expected by chance. There is 
statistically significant change (p=<0.001). 
DISCUSSION  
Observations were made in the 10 patients before 
treatment and after treatment The three subjective 
criteria were; 
1. Vibhandha 
2. Kandu 
3. Rakta Srava 
All the criteria were recorded BT and AT according to 
the gradings devised in the assessment critera of 
proforma. At the end of the study, they were assessed 
by questioning the patients and by clinical 
examination. The BT/AT readings were also analysed 
for statistical significance. 
Vibhandha: 7 among the 10 patients had moderate 
constipation BT: Other 2 had mild constipation and 1 
patient had severe Vibhandha. At the end of the 
treatment, among the 7 patients who had moderate 
level of constipation, all 7 reported complete relief 
from Vibhandha. The 2 patients who had mild 
constipation BT reported complete relief from 
constipation at the end of the treatment. One patient, 
who had severe Vibhandha BT, said that his 
constipation has reduced to ‘mild’. The BT/AT 
recordings of the Vibhandha, when analysed were 
statistically significant. 
Kandu: When questioned, it was found that all the 10 
patients had Kandu. Among the 10 patients, 6 had 
moderate pruritus and 4 of mild pruritus BT. After the 
treatment; it was found that 5 among the 6 patients 
who had moderate degree of Kandu had reported 
that they did not have the symptom any longer. One 
patient who had moderate Kandu BT, reported that 
the Kandu had reduced to mild AT. The other 4 
patients who had mild pruritus are completely 
symptom free AT. The BT/AT recordings showed 
statistical significance. 
Rakta Srava: Among the 10 patients, all patients 
complained Raktasrava before treatment. 6 patients 
had moderate bleeding BT. Among these 6 patients, 
bleeding had reduced to mild AT. The remaining 4 
patients had mild bleeding BT. But there was no 
bleeding in these 4 patients AT. All the 4 patients had 
become symptom free AT. The BT/AT readings 
showed statistical significance on analysis. 
Follow-up 
Among the 10 patients, 1 patient was symptom free 
during the 3 month follow-up period. In 9 patients, 
there was a reappearance of symptoms.  
In 1 patient moderate bleeding has reduced to mild 
bleeding AT.  
But during first 2 follow-up, the bleeding remained 
same and then stopped, in the next 2 follow-up. But 
the mild bleeding again started in the next 2 follow-
up. In 9 patients constipation was completely relieved 
after treatment, and there was no constipation during 
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first 4 follow-up. But reappeared in 8 cases during 5
th
 
follow-up and remained same i.e, mild constipation in 
9 cases during 6
th
 follow-up. In 1 patient severe 
constipation has converted into mild form after 
treatment and remained in mild form during first 
follow-up and in the next 2 follow-ups there was no 
constipation but reappeared in the next 2 visits in 
mild form. 
There was no pruritus in 8 patients after treatment. 
But reappeared in mild form during 4
th
 follow-up in 2 
patients. During 5
th
 follow-up it was found in mild 
form in 7 cases. During 6
th
 follow-up pruritus was 
found in mild form in 9 cases. In 4 patients there was 
no bleeding after treatment and in 6 patients 
moderate form of bleeding has reduced to mild form 
after treatment. In 7 patients bleeding reappeared in 
mild form during the first follow up itself. In second 
follow-up bleeding was present in mild form in 5 
patients. During 3
rd
 follow-up bleeding was present in 
mild form in only one case. 
During 4
th
 follow-up bleeding was present in 3 
patients. During 5
th
 & 6
th
 follow-up bleeding was 
present in mild form in 9 patients. After analyzing 
symptoms during the follow up visits revealed that 
there was a reappearance of symptoms in 9 cases. 
Only 1 patient had complete relief even after follow 
up for 3 months. 
CONCLUSION  
Nature of work and irregular dietary habit contribute 
to the manifestation of Arshas was observed during 
the study. All the patients were the victims of 
Madagni was observed. The medicine significantly 
helped in increasing the Agni, and helped a lot in 
relieving the constipation, pruritis and to some extent 
in reducing the bleeding. But during the follow up, 
reappearance of the symptoms was observed. So no 
single therapy can be set to be self sufficient in the 
management of all types of Arshas because of their 
limitations and different objectives. So medicinal 
treatment is a therapy that can be advised in 
haemorrhoidal patients having milder or vague 
complaints with satisfactory results. 
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